PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is a significant public health challenge afflicting approximately 1 billion individuals both in the Western world and in the East world. While liver biopsy is considered as gold standard in the diagnosis and staging of liver fibrosis, noninvasive imaging tech...
Saved in:
Main Authors: | Tuo Shao PhD, Lee Josephson PhD, Steven H. Liang PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-09-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.1177/1536012119871455 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO
by: Vidya Narayanaswami PhD, et al.
Published: (2018-09-01) -
Whole-Body Biodistribution, Dosimetry, and Metabolite Correction of [C]Palmitate: A PET Tracer for Imaging of Fatty Acid Metabolism
by: Nana L. Christensen MLS, et al.
Published: (2017-10-01) -
Longitudinal Evaluation of Myocardial Fatty Acid and Glucose Metabolism in Fasted and Nonfasted Spontaneously Hypertensive Rats Using MicroPET/CT
by: Jennifer S. Huber PhD, et al.
Published: (2017-08-01) -
Detecting Demyelination by PET: The Lesion as Imaging Target
by: Pedro Brugarolas PhD, et al.
Published: (2018-07-01) -
Multiscale Mask R-CNN–Based Lung Tumor Detection Using PET Imaging
by: Rui Zhang PhD, et al.
Published: (2019-07-01)